Dolomite Bio launches the Nadia single cell platform, a groundbreaking system designed to escalate scRNA-Seq to new heights.
Offering an innovative solution for a wide range of potential applications in the fast-growing single cell research sector, the Nadia instrument is a touchscreen-controlled, droplet-based microfluidic platform for single cell research. Combining superior microfluidics, automated temperature control and gentle cell/bead agitation in a single compact instrument, it delivers highly precise and reliable results.
One, two, four or eight samples can be run in parallel, generating up to 6,000 high quality, single cell libraries per sample in approximately 15 minutes. Configuration with the Nadia Innovate protocol development platform transforms the system into a scalable, open system for the creation of new procedures and applications. Users can alter parameters – such as droplet size and frequency, temperature, agitation and timings – and optimise protocols with the aid of real-time visualisation, enabling straightforward development of new single cell protocols and applications.
Mike Hawes, CEO of Dolomite Bio, said:: “We are excited to be launching the Nadia product family. This novel system represents a huge leap forward for single cell research, and we look forward to showcasing its capabilities.”
To read more, please click here.
